ISOVUE
Total Payments
$2.6M
Transactions
657
Doctors
263
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $162.13 | 2 | 2 |
| 2023 | $201,837 | 27 | 14 |
| 2022 | $176,635 | 37 | 20 |
| 2021 | $163,308 | 21 | 4 |
| 2020 | $370,030 | 50 | 11 |
| 2019 | $531,410 | 33 | 8 |
| 2018 | $121,571 | 15 | 5 |
| 2017 | $1.0M | 472 | 211 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $1.1M | 20 | 41.4% |
| Consulting Fee | $479,649 | 116 | 18.5% |
| Royalty or License | $376,627 | 36 | 14.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $286,434 | 17 | 11.1% |
| Unspecified | $133,612 | 28 | 5.2% |
| Honoraria | $93,500 | 30 | 3.6% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $42,515 | 10 | 1.6% |
| Food and Beverage | $34,835 | 357 | 1.3% |
| Travel and Lodging | $31,350 | 36 | 1.2% |
| Education | $20,000 | 1 | 0.8% |
| Charitable Contribution | $9,960 | 3 | 0.4% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $9,000 | 3 | 0.3% |
Payments by Type
General
$2.5M
629 transactions
Research
$133,612
28 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A PROSPECTIVE, MULTICENTER OBSERVATIONAL STUDY TO EVALUATE THYROID FUNCTION OF PEDIATRIC SUBJECTS FROM BIRTH TO 3 YEARS EXPOSED TO ISOVUE (IOPAMIDOL INJECTION) | BRACCO DIAGNOSTICS INC. | $66,507 | 1 |
| A PROSPECTIVE, MULTICENTER OBSERVATIONAL STUDY TO EVALUATE THYROID FUNCTION OF PEDIATRIC SUBJECTS FROM BIRTH TO 3 YEARS EXPOSED TO ISOVUE (IOPAMIDOL INJECTION) | Bracco Diagnostics Inc. | $35,827 | 0 |
| A Prospective, Multicenter Observational Study To Evaluate Thyroid Function Of Pediatric Subjects From Birth To 3 Years Exposed To Isovue (Iopamidol Injection) | Bracco Diagnostics Inc. | $9,724 | 0 |
| AN AUTOPSY TISSUE STUDY FOR QUANTIFICATION OF GADOLINIUM LEVELS AND HISTOPATHOLOGICAL CHANGES FROM SUBJECTS WHO RECEIVED A GADOLINIUM-BASED CONTRAST AGENT (MULTIHANCE, GADAVIST, DOTAREM, OR PROHANCE) | Bracco Diagnostics Inc. | $8,553 | 0 |
| A Prospective, Multicenter Observational Study to Evaluate Thyroid Function of Pediatric Subjects From Birth to 3 Years Exposed to Isovue (Iopamidol Injection) | Bracco Diagnostics Inc. | $4,222 | 0 |
| A Prospective Multicenter Observational Study to Evaluate Thyroid Function of Pediatric Subjects from Birth to 3 Years Exposed to ISOVUE (IOPAMIDOL INJECTION) | Bracco Diagnostics Inc. | $3,049 | 0 |
| AN OBSERVATIONAL STUDY OF SONOVUE/LUMASON-ENHANCED UROSONOGRAPHY IN PAEDIATRIC SUBJECTS WITH KNOWN OR SUSPECTED VESICOURETERAL REFLUX | Bracco Diagnostics Inc. | $1,813 | 0 |
| A prospective, multicenter observational study to evaluate thyroid function of pediatric subjects from birth to 3 years exposed to Isovue (Iopamidol injection) | Bracco Diagnostics Inc. | $1,654 | 0 |
| IOP-120 | Bracco Diagnostics Inc. | $1,068 | 0 |
| FLUORESCENCE PROJECT | BRACCO DIAGNOSTICS INC. | $825.00 | 1 |
| Protocol No. IOP-120: A Prospective Multicenter Observational Study to Evaluate Thyroid Function of Pediatric Subjects from Birth to 3 Years Exposed to ISOVUE (IOPAMIDOL INJECTION) | Bracco Diagnostics Inc. | $371.70 | 0 |
Top Doctors Receiving Payments for ISOVUE — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Diagnostic Radiology | Grand Rapids, MI | $4,994 | 5 |
| , M.D | Nuclear Medicine | Minneapolis, MN | $4,949 | 7 |
| , M.D | Diagnostic Radiology | San Diego, CA | $4,075 | 1 |
| , MD | Diagnostic Radiology | New Haven, CT | $3,448 | 3 |
| , MD | Diagnostic Radiology | New York, NY | $3,118 | 3 |
| , MD | Internal Medicine | Marrero, LA | $3,118 | 2 |
| , M.D | Neuroradiology | Springfield, IL | $2,500 | 2 |
| , MD | Diagnostic Radiology | Stanford, CA | $2,365 | 4 |
| , M.D | Diagnostic Radiology | Durham, NC | $2,025 | 4 |
| , M.D | Diagnostic Radiology | St Louis Park, MN | $2,000 | 1 |
| , M.D | Cardiovascular Disease | Rochester, MN | $1,810 | 7 |
| , MD | Cardiovascular Disease | Palo Alto, CA | $1,807 | 5 |
| , M.D | Diagnostic Radiology | San Diego, CA | $1,805 | 3 |
| , DO | Cardiovascular Disease | Portland, OR | $1,776 | 2 |
| , M.D | Neuroradiology | Los Angeles, CA | $1,765 | 5 |
| , MD | Diagnostic Radiology | Boston, MA | $1,735 | 8 |
| , MD | Diagnostic Radiology | Los Angeles, CA | $1,664 | 2 |
| , MD | Body Imaging | Chapel Hill, NC | $1,524 | 2 |
| , MD | Diagnostic Radiology | Syracuse, NY | $1,500 | 1 |
| , MD | Cardiovascular Disease | The Dalles, OR | $1,428 | 5 |
| , MD | Internal Medicine | Portland, OR | $1,250 | 1 |
| , MD | Otolaryngology | Nashville, TN | $825.00 | 1 |
| , MD, PHD | Diagnostic Radiology | Rochester, MN | $739.18 | 4 |
| , MD | Diagnostic Radiology | Omaha, NE | $602.86 | 5 |
| , MD | Specialist | Pittsburgh, PA | $558.37 | 3 |
Ad
Manufacturing Companies
- BRACCO DIAGNOSTICS INC. $2.0M
- Bracco Diagnostics Inc. $555,050
- Acist Medical Systems, Inc. $64,984
Product Information
- Type Drug
- Total Payments $2.6M
- Total Doctors 263
- Transactions 657
About ISOVUE
ISOVUE is a drug associated with $2.6M in payments to 263 healthcare providers, recorded across 657 transactions in the CMS Open Payments database. The primary manufacturer is BRACCO DIAGNOSTICS INC..
Payment data is available from 2017 to 2024. In 2024, $162.13 was paid across 2 transactions to 2 doctors.
The most common payment nature for ISOVUE is "Grant" ($1.1M, 41.4% of total).
ISOVUE is associated with 11 research studies, including "A PROSPECTIVE, MULTICENTER OBSERVATIONAL STUDY TO EVALUATE THYROID FUNCTION OF PEDIATRIC SUBJECTS FROM BIRTH TO 3 YEARS EXPOSED TO ISOVUE (IOPAMIDOL INJECTION)" ($66,507).